BRPI0920752A2 - dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo - Google Patents

dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo

Info

Publication number
BRPI0920752A2
BRPI0920752A2 BRPI0920752A BRPI0920752A BRPI0920752A2 BR PI0920752 A2 BRPI0920752 A2 BR PI0920752A2 BR PI0920752 A BRPI0920752 A BR PI0920752A BR PI0920752 A BRPI0920752 A BR PI0920752A BR PI0920752 A2 BRPI0920752 A2 BR PI0920752A2
Authority
BR
Brazil
Prior art keywords
octreotide
distribution
methods
implantable device
implantable
Prior art date
Application number
BRPI0920752A
Other languages
English (en)
Inventor
Harry Quandt
Petr Kuzma
Original Assignee
Endo Pharmaceuticals Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Solutions filed Critical Endo Pharmaceuticals Solutions
Publication of BRPI0920752A2 publication Critical patent/BRPI0920752A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0920752A 2008-09-30 2009-09-29 dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo BRPI0920752A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10155208P 2008-09-30 2008-09-30
PCT/US2009/058801 WO2010039717A1 (en) 2008-09-30 2009-09-29 Implantable device for the delivery of octreotide and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0920752A2 true BRPI0920752A2 (pt) 2015-12-22

Family

ID=41557438

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920752A BRPI0920752A2 (pt) 2008-09-30 2009-09-29 dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo

Country Status (14)

Country Link
US (4) US20110244015A1 (pt)
EP (1) EP2344122A1 (pt)
JP (1) JP2012504144A (pt)
KR (1) KR20110066934A (pt)
CN (1) CN102202645A (pt)
AU (1) AU2009298711B2 (pt)
BR (1) BRPI0920752A2 (pt)
CA (1) CA2739180C (pt)
IL (1) IL211953A (pt)
MX (1) MX2011003300A (pt)
RU (1) RU2549473C2 (pt)
UA (1) UA105502C2 (pt)
WO (1) WO2010039717A1 (pt)
ZA (1) ZA201102949B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CN102202646A (zh) 2008-09-30 2011-09-28 Endo药物方法有限公司 用于输送利培酮的可植入装置及其使用方法
EP2344122A1 (en) * 2008-09-30 2011-07-20 Endo Pharmaceuticals Solutions Inc. Implantable device for the delivery of octreotide and methods of use thereof
JP2014530913A (ja) * 2011-10-24 2014-11-20 エンドゥ ファーマシューティカルズ ソリューションズ インコーポレイティド 移植可能ラサギリン組成物及びその治療方法
WO2013063079A1 (en) 2011-10-24 2013-05-02 Endo Pharmaceuticals Solutions Inc. Implantable tizanidine compositions and methods of treatment thereof
CN107582514A (zh) * 2011-10-24 2018-01-16 布雷本制药有限公司 可植入的药物递送组合物及其治疗方法
US9493991B2 (en) 2012-04-02 2016-11-15 Baker Hughes Incorporated Cutting structures, tools for use in subterranean boreholes including cutting structures and related methods
BR112015022433B1 (pt) 2013-03-15 2022-06-21 Taris Biomedical Llc Dispositivo de liberação de droga intravesical
WO2015184407A1 (en) * 2014-05-30 2015-12-03 Textile-Based Delivery, Inc. Drug delivery systems and related methods of use
EP3285850A1 (en) 2015-04-23 2018-02-28 TARIS Biomedical LLC Drug delivery devices with drug-permeable component and methods
US11820890B2 (en) 2021-04-01 2023-11-21 Stratasys Inc Pulverulent thermoplastic polymer blends

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
KR100622332B1 (ko) * 1999-04-01 2006-09-13 알자 코포레이션 폴리우레탄 약물 리저버를 함유하는 경피 약물 수송 장치
ATE431113T1 (de) * 2002-05-23 2009-05-15 Active Implants Corp Gelenk- und zahnimplantate
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
PT1781264E (pt) * 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
CN101193626A (zh) * 2005-03-11 2008-06-04 益德威士医药股份有限公司 奥曲肽的受控释放制剂
WO2009158415A1 (en) * 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent
EP2344122A1 (en) * 2008-09-30 2011-07-20 Endo Pharmaceuticals Solutions Inc. Implantable device for the delivery of octreotide and methods of use thereof

Also Published As

Publication number Publication date
WO2010039717A1 (en) 2010-04-08
US20190365847A1 (en) 2019-12-05
MX2011003300A (es) 2011-06-09
RU2011117327A (ru) 2012-11-10
US20110244015A1 (en) 2011-10-06
CA2739180C (en) 2017-12-19
US20150283201A1 (en) 2015-10-08
IL211953A0 (en) 2011-06-30
EP2344122A1 (en) 2011-07-20
IL211953A (en) 2015-11-30
JP2012504144A (ja) 2012-02-16
ZA201102949B (en) 2015-12-23
US20210161994A1 (en) 2021-06-03
CN102202645A (zh) 2011-09-28
AU2009298711A1 (en) 2010-04-08
RU2549473C2 (ru) 2015-04-27
KR20110066934A (ko) 2011-06-17
AU2009298711B2 (en) 2015-10-29
UA105502C2 (uk) 2014-05-26
CA2739180A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
BRPI0920752A2 (pt) dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo
BRPI0919465A2 (pt) dispositivo implantável para a liberação de risperidona e métodos de uso do mesmo
BRPI1013432A2 (pt) derivado de indolizina e uso do mesmo para propósitos médicos
BRPI0910960A2 (pt) método para monitoramento do uso não autorizado de um dispositivo
BR112012010991A2 (pt) âncoras de implante e cabelo e sistemas e métodos para seu uso
CO6821883A2 (es) Nuevos moduladores y métodos para su uso
BRPI0908379A2 (pt) sistemas e métodos para obter dentaduras customizadas
BR112013009835A2 (pt) dispositivo para a remoção de material e método de uso
BR112013016226A2 (pt) dispositivo de sutura, método de uso de um dispositivo de sutura e material de sutura de tecido
DE602008002815D1 (de) Knochenverankerungsvorrichtung
BRPI0813989A2 (pt) Dispositivo e método de retração de tecido gengival
BRPI0917141A2 (pt) implante de stent dotado de área de assentamento estendida e método para uso do mesmo
EP2129429A4 (en) ANCHORING APPARATUS AND METHODS OF USE
BRPI0821648A2 (pt) Método e dispositivo para pó desagregante
BRPI0907257A8 (pt) sistemas e métodos para estimulação elétrica terapêutica
DE602007007758D1 (de) Knochenverankerungsvorrichtung
DE602007007466D1 (de) Knochenverankerungsvorrichtung
EP2344484A4 (en) MODULATORS OF S1P RECEIVERS AND THEIR USE
BR112012004151A2 (pt) "método e dispositivo para verificar senha dinâmica"
BRPI0914862A2 (pt) método e dispositivo para colocação de implante
BRPI0816835A2 (pt) dispositivo de pulverização e método de uso do mesmo
BRPI0905983A2 (pt) Método e aparelho para calcinação de gesso pressurizado
BRPI0910763A2 (pt) métodos e dispositivos para dissecção de tecidos
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BRPI0906352A2 (pt) Derivado de tiazol e uso do mesmo como inibidores de vap-1

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]